Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,
Full Article
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Motley Fool
0 shares
1 views
You might like
Related news coverage
Arm Stock Has 20% Downside, According to 1 Wall Street Analyst
Motley Fool
Investors bid up Arm after earnings, but that was exactly the wrong decision.